Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc

February 10, 2016 Leave a comment 2,389 Views

OCEANSIDE, CA–(Marketwired – February 08, 2016) – Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Company has licensed their Exosome Patent to MolecuVax, Inc. (“MVAX”) a wholly owned subsidiary of Therapeutic Solutions International, Inc. (“TSI”) where the ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Immune Stimulation

Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc

Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin

Overcoming Chemoresistance via Extracellular Vesicle Inhibition

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Study focuses on a different kind of liquid biopsy to detect cancer

Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition